Search

Displaying results 2921 - 2930 of 7706 in total
  1. Drug

    Imazodan

    go.drugbank.com/drugs/DB20144
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Imazodan is a cardiac stimulant, pimobendan derivative. Imazodan has a monoisotopic molecular weight of 240.1 Da.

  2. Drug

    Thyromedan

    go.drugbank.com/drugs/DB20438
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Thyromedan is a cardiac stimulant, pimobendan derivative. Thyromedan has a monoisotopic molecular weight of 734.88 Da.

  3. Drug

    Prinoxodan

    go.drugbank.com/drugs/DB21318
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Prinoxodan is a cardiac stimulant, pimobendan derivative. Prinoxodan has a monoisotopic molecular weight of 258.11 Da.

  4. Drug

    Anthrax immune globulin human

    go.drugbank.com/drugs/DB09057
    ApprovedInvestigational

    Available as the product Anthrasil (FDA), the result is a solution for slow IV infusion containing polyclonal antibodies that bind the protective antigen (PA) component of Bacillus anthracis lethal and

  5. Drug

    Pegzilarginase

    go.drugbank.com/drugs/DB14780
    Approved

    FDA in February 2026 for the treatment of hyperargininemia in adult and pediatric patients aged 2 years and older with ARG1-D, to be used in conjunction with dietary protein restriction. … Pegzilarginase is a recombinant, cobalt-substituted, and pegylated human arginase 1 enzyme therapy designed to address the underlying metabolic deficit in arginase 1 deficiency (ARG1-D).

  6. Drug

    Ferrous glycine sulfate

    go.drugbank.com/drugs/DB14501
    Approved

  7. Drug

    Pranlukast

    go.drugbank.com/drugs/DB01411
    Investigational

    It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.

  8. Drug

    Epicept NP-1

    go.drugbank.com/drugs/DB05492
    Investigational

    EpiCept NP-1 Cream is a patented formulation containing two FDA-approved drugs, amitriptyline (a widely-used antidepressant) and ketamine (an NMDA antagonist that is used as an anesthetic).

  9. Target

    Immunoglobulin kappa variable 2D-28

    go.drugbank.com/bio_entities/BE0004341
    TargetHumans

    V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocy...

    Synonyms: Ig kappa chain V-II region FR
  10. Drug

    Lomustine

    go.drugbank.com/drugs/DB01206
    ApprovedInvestigational

    An alkylating agent of value against both hematologic malignancies and solid tumors.